Related Experiment Video
Updated: Jan 25, 2026

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
Published on: March 4, 2017
Bridging communities in the field of nanomedicine
Blanka Halamoda-Kenzaoui1, Simon Baconnier2, Thierry Bastogne3
1European Commission Joint Research Centre (JRC), Ispra, Italy.
Abstract:
An early dialogue between nanomedicine developers and regulatory authorities are of utmost importance to anticipate quality and safety requirements for these innovative health products. In order to stimulate interactions between the various communities involved in a translation of nanomedicines to clinical applications, the European Commission's Joint Research Centre hosted a workshop titled "Bridging communities in the field of Nanomedicine" in Ispra/Italy on the 27th -28th September 2017. Experts from regulatory bodies, research institutions and industry came together to discuss the next generation of nanomedicines and their needs to obtain regulatory approval. The workshop participants came up with recommendations highlighting methodological gaps that should be addressed in ongoing projects addressing the regulatory science of nanomedicines. In addition, individual opinions of experts relevant to progress of the regulatory science in the field of nanomedicine were summarised in the format of a survey.
Related Concept Videos
What are Populations and Communities?
Design Example: Strain Gauge Bridge or Wheatstone Bridge
Bridge rectifier
Operationally, the bridge rectifier allows current flow through two of its diodes during each...
Wheatstone Bridge
Thus, for accurate resistance measurements, a...
Cross-bridge Cycle
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...

